Analyst Ratings for Incyte (INCY)
INCY Rating Summary
INCY Price Target Summary
- Highest: $37.00 (Jefferies)
- Lowest: $17.00 (Goldman Sachs)
- Average: $25.36
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$25.36 (+10.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2013 | Goldman Sachs | New Coverage | Sell (N/A) |
17.00 (N/A) |
22.54 | 23.00 | 2.04% | Details |
| 1/23/2013 | Morgan Stanley | Downgrade | Underweight (Equalweight) |
N/A (N/A) |
19.18 | 23.00 | 19.92% | Details |
| 1/14/2013 | Lazard Capital | Upgrade | Buy (Neutral) |
25.00 (N/A) |
18.20 | 23.00 | 26.37% | Details |
| 11/9/2012 | Guggenheim | New Coverage | Buy (N/A) |
27.00 (N/A) |
16.50 | 23.00 | 39.39% | Details |
| 3/30/2012 | ThinkEquity | New Coverage | Buy (N/A) |
25.00 (N/A) |
19.87 | 23.00 | 15.75% | Details |
| 3/26/2012 | Canaccord Genuity » Updated 8/3/2012 |
New Coverage | Buy (N/A) |
25.00 (N/A) |
19.80 | 23.00 | 16.16% | Details |
| 12/9/2011 | Barclays » Updated 8/30/2012 |
New Coverage | Equalweight (N/A) |
21.00 (N/A) |
13.40 | 23.00 | 71.64% | Details |
| 12/5/2011 | Citi | Downgrade | Neutral (N/A) |
N/A (N/A) |
14.24 | 23.00 | 61.52% | Details |
| 6/10/2011 | Piper Jaffray | New Coverage | Overweight (N/A) |
N/A (N/A) |
18.16 | 23.00 | 26.65% | Details |
| 5/3/2011 | Leerink Swann » Updated 10/13/2011 |
Upgrade | Outperform (N/A) |
N/A (N/A) |
18.26 | 23.00 | 25.96% | Details |
| 4/8/2011 | UBS » Updated 4/27/2012 |
Upgrade | Buy (N/A) |
26.00 (N/A) |
16.46 | 23.00 | 39.73% | Details |
| 4/6/2011 | Wells Fargo | New Coverage | Market Perform (N/A) |
N/A (N/A) |
16.45 | 23.00 | 39.82% | Details |
| 3/16/2011 | Gleacher & Co. | Upgrade | Buy (N/A) |
N/A (N/A) |
13.88 | 23.00 | 65.71% | Details |
| 2/17/2011 | BMO Capital | New Coverage | Market Perform (N/A) |
N/A (N/A) |
14.67 | 23.00 | 56.78% | Details |
| 1/3/2011 | Monness, Crespi, Hardt | Downgrade | Sell (N/A) |
N/A (N/A) |
16.56 | 23.00 | 38.89% | Details |
